Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.34 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.34 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.32 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.32 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.32 |
| ▸ | CCL2 | P13500 | 1/20 | 0.32 |
| ▸ | CCL5 | P13501 | 1/20 | 0.32 |
| ▸ | IGF2R | P11717 | 1/20 | 0.32 |
| ▸ | BMP2 | P12643 | 1/20 | 0.30 |
| ▸ | VEGFA | P15692 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19390477 | 0.89 | CYP3A4 (0.42) | MAPK1MEN1KMT2ALGALS3LGALS8 | |
| SCHEMBL19390475 | 0.89 | CYP3A4 (0.42) | MAPK1MEN1KMT2ALGALS3LGALS8 | |
| SCHEMBL10261606 | 0.89 | CYP3A4 (0.42) | MAPK1MEN1KMT2ALGALS3LGALS8 | |
| SCHEMBL26257060 | 0.89 | CYP3A4 (0.42) | MAPK1MEN1KMT2ALGALS3LGALS8 | |
| SCHEMBL29330037 | 0.87 | CYP3A4 (0.43) | MAPK1MEN1KMT2ALGALS3LGALS8 | |
| SCHEMBL25746360 | 0.87 | CYP3A4 (0.43) | MAPK1MEN1KMT2ALGALS3LGALS8 | |
| SCHEMBL26257131 | 0.86 | MAPK1 (0.37) | MAPK1MEN1KMT2ALGALS3LGALS8 | |
| SCHEMBL19930017 | 0.82 | CYP3A4 (0.47) | MAPK1MEN1KMT2ALGALS3LGALS8 | |
| SCHEMBL19769332 | 0.81 | KMT2A (0.38) | MAPK1MEN1KMT2ALGALS3CYP3A4 | |
| SCHEMBL18503708 | 0.79 | CYP3A4 (0.43) | MAPK1MEN1KMT2ALGALS3LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018523-A1 | GALNAC COMPOSITIONS FOR IMPROVING SIRNA BIOAVAILABILITY | EMPIRICO INC. | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018523-A1 | GALNAC COMPOSITIONS FOR IMPROVING SIRNA BIOAVAILABILITY | CSGALNACT1, B3GAT3, UGGT1 | MAPK1 4631/4885MEN1 3283/4885KMT2A 2835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.